Takeda Shareholders Approve Dividends and Directors

Takeda Pharmaceutical Company (TAK) has released an update.

Takeda Pharmaceutical Company has reported the outcomes of their 148th Ordinary General Meeting of Shareholders held on June 26, 2024, which included the approval of a year-end dividend of 94 yen per share, the election of fourteen directors, and the approval of bonuses for directors. Shareholders voted in favor of all proposals with high approval rates, ensuring the company’s governance and financial decisions are in line with investor expectations.

For further insights into TAK stock, check out TipRanks’ Stock Analysis page.